logo

Acasti Pharma, Inc. (ACST)



Trade ACST now with
  Date
  Headline
5/10/2019 7:35:16 AM Acasti Pharma Settles Claims Made By Its Former CEO
12/31/2018 8:01:54 AM Acasti Pharma Announces TRILOGY Phase 3 Trials Of CaPre
12/20/2018 8:14:24 AM Acasti Pharma Reaches Enrollment Targets For TRILOGY Phase 3 Trials Of CaPre In Patients With Severe HTG
11/14/2018 8:16:36 AM Acasti Pharma Q2 Net Loss C$22.7 Mln Or C$0.62 Per Share
10/3/2018 4:30:57 PM Acasti Pharma Announces Proposed Public Offering Of Common Shares
9/24/2018 8:07:17 AM Acasti Pharma Appoints Jean-François Boily As VP Of Finance; Announces Planned Retirement Of Current CFO Linda O’Keefe
5/18/2018 7:02:54 AM Acasti Pharma Retains Crescendo Communications For Investor Relations Services In The United States
4/23/2018 3:50:30 PM Acasti Pharma, Trading Halt ; Pending News
3/14/2018 8:08:55 AM Acasti Announces First Patient Randomized In Pivotal TRILOGY Phase 3 Program Of CaPre In Severe Hypertriglyceridemia
3/14/2018 8:06:40 AM Acasti Pharma Says First Patient Randomized In Pivotal TRILOGY Phase 3 Program Of CaPre In Severe Hypertriglyceridemia
1/8/2018 7:04:50 AM Acasti Pharma Reports Issuance Of Common Shares In Payment Of Outstanding Interest Under Debentures
  
 
>